Silicon Valley pursues advancements in health and technology to extend human life. Innovators invest in research on genetics, biotechnology, and artificial intelligence to enhance longevity. Companies explore various methods, such as gene editing and anti-aging treatments, to combat aging. Scientists and entrepreneurs debate ethical implications surrounding these developments. Some focus on the potential for significant lifespan extension, while others raise concerns about social inequality and access to such technologies. The conversation highlights a growing interest in mortality and the future of human life. Learn more on this news visit us at: https://greyjournal.net/news/ Hosted on Acast. See acast.com/privacy for more information.